Share
Cancelled
HealthTech Portugal
Lisboa, PT
instalment
monthly
term
1 year
yearly interest
5.75%
risk rating
C+
Description
HealthTech Lisboa is a venture builder whose mission is to support the creation of companies and startups in health technologies and entrepreneurs in their first years of activity.
As part of its activity, network, and based on its know-how, HealthTech Lisboa is developing a project called Healthtech Portugal - a response to the challenges of Digital Transformation - providing crucial infrastructure for SMEs and startups to test and validate their solutions in the area of health, medical devices, health tech, and cosmetics. This project provides services so that SMEs and startups in the sector can scale their business at a competitive cost, making their products and services commercially viable and giving the necessary support to significantly increase the success rate of entrepreneurs.
The project's primary goal is to provide a differentiating solution, having already been approved by the "Desenvolvimento de Projetos no âmbito da medida Rede Nacional de Test Beds" (Development of Projects under the National Network of Test Beds), which is also a source of funding. To secure further funding, HealthTech Portugal is launching this campaign.
The funds raised through Gopsarity's impact investing community will be used to achieve the following objectives:
- Simulate and test innovative health products or services with a solid technological or digital component to achieve a Technology Readiness Level between levels 5 and 9.
- Create highly qualified jobs.
- Create partnerships with relevant entities in health and MedTech (technology for medicine).
- Provide capacity-building services to SMEs and startups.
- Accelerate growth and market readiness for SMEs and startups in the health area.
- Ensure the economic and financial sustainability of the project in the post-financing period.
HealthTech Portugal aims to contribute to the development and consolidation of the biomedicine cluster, medical devices, and health technology in Portugal, considered strategic action points by the previous Portuguese Government for the central region of the country where it will be implemented (Covilhã). The project will promote technology and scientific know-how transfers from universities and national and international R&D institutions, creating opportunities for links between academia and business, as well as opportunities for the co-creation of solutions by all stakeholders in the system.
The Impact
- Support and promotion of innovation and entrepreneurship: Healthtech Portugal is part of the national test bed network. A solution for small and medium enterprises (SMEs) and technology startups in the health area to test, validate and scale their business solutions. Initiatives in the area are driven to achieve high levels of technology readiness, to increase their success rate by 50%. The goal is to initially provide simulation and testing for 99 products or services with a strong technological and/or digital component, and to accelerate the growth and market adaptation of at least 26 SMEs and startups in the area of medical devices, health technology, pharmaceuticals and cosmetics.
- Promotion of partnerships for knowledge and technology sharing: by connecting established companies, SMEs, startups and universities and institution of innovation and technological development, the project promotes the formation of partnerships between these actors for the co-creation of solutions, enabling the transfer and sharing of technology and scientific knowledge.
- Promoting development in a strategic region of Portugal: the biomedicine and health technology sector is boosted with the implementation of the project in Covilhã, central region of Portugal.
- Job creation: the project aims to create 10 highly qualified jobs for the operationalization of the test bed.
Impact Indicators
10
jobs created
Contribution to the Sustainable
Development Goals
Sustainable Development Goals
.4efc673.png)
.b54aa7b.png)
Financial viability
This loan will be repaid 12 months after the start of the contract, including 100% of the amount financed and the interest offered to investors. The money to repay will come from the business generated and the grant to be received under the RRP. This project will be co-financed by four international investors in addition to the RRP grant. HealthTech anticipates a significant increase in sales due to the investments made through this funding.
The Promoter
About Positivazimute, Lda
Positivazimute, Lda is the company behind the brand HealthTech Lisboa (leader of HealthTech Portugal). Founded in 2019 by Portuguese entrepreneurs and organizations, HealthTech Lisboa deems an important role in Portuguese health tech, focusing on the medical devices sector.
The company wants to promote the acceleration and growth of startups and pioneering projects in health technologies and medical devices through mentoring and support in developing concepts, business plans, structuring, financing, marketing, and sales, increasing competitiveness in the global market.
HealthTech Lisboa is located in LISPOLIS – Polo Tecnológico de Lisboa, where it started as a founding partner. LISPOLIS is a private non-profit association that manages the Polo Tecnológico de Lisboa (a tech hub) for technological and innovative companies that has been operating for almost 30 years to support the growth of startups, SMEs, and multinationals. Currently, LISPOLIS is home to more than 125 companies.
Through its multidisciplinary team's know-how, HealthTech Lisboa has access to skills and a strategic network of contacts at a global level. HealthTech Lisboa also relays on several qualified mentors with extensive international experience in tech, banking, health, finance, manufacturing, consumer goods, sports, and fashion. These mentors, some of who were founders of HealthTech Lisboa, add value to the startup's intellectual property (IP), help to get pilots, enter the market, and achieve scale.
Lisbon Healthtech stands out as a startup optimizer, betting on capacitation, development, promotion, and modernization within the health ecosystem. Their focused strategy on innovation and competitiveness for efficient technological and digital solutions aims to ensure change for the health paradigm using software development, artificial intelligence (AI), and computer vision. HealthTech Lisboa promotes relationships between stakeholders, assisting SMEs and startups in improving products and services to meet the industry's needs.
The team
Lars Wahlstrom
Co-founder of Healthtech Lisboa. Also, co-founder of Viser Hispania, which is introducing patient alarms to the elderly care sector. Lars acts as an advisor to private equity funds and invests and participates in various projects. He holds experience in the technology sector as an international executive at Oracle and other smaller companies.
Luis Fatela
A passionate leader with first-class communication skills and a long track record of successful management. Luis has experience leading and developing people and organizations. Extensive knowledge of the current pharmaceutical business. Able to push performance improvement whilst at the same time delivering growth. Possessing managing and CEO experience he wants to ensure that clear objectives and expectations are delivered and maintained.
Ljiljana Dukanovic
Managing and strategic planning of R&D activities in a healthtech start up; Diverse experience in academic and industry contexts; International professional experience and education; Business Management training; Leadership experience; Interdisciplinary undergraduate education in biology and art history; Proactive and driven personality, with critical thinking, independence, strong communication skills, adaptability and motivation to become a productive and invested citizen.
Tiago Vilaças
Tiago is a finance specialist with an undergraduate degree in Finance and Accounting and a graduate degree in Finance. He has worked in audit firms for five years, performing audit services in pension funds, investment funds, and public institutions, among others.
Vitor Crespo
Specialist in: Business Management; Channel Management; Venture Capital; Business Angel; Business Scaling; Fund Raising; Mentoring/Coaching; Management; Sales Management; People Management; Business Area Lead; C-Level Negotiations.
Vânia Fernandes
Marketing professional with experience in the areas of Finance, Education, and Fashion. Dedicated the last five years of his career to the area of health, supporting several companies in their journey of innovation and technological development in this area. Holds a Master's in Marketing, Innovation, and Strategy from Nova School of Business and Economics.
Vasco Lopes
Co-Founder and CEO of DeepNeuronic, Researcher and Ph.D. Student at NOVA School of Science and Technology, Full-time Researcher at Google, and Guest Lecturer at Universidade da Beira Interior. He has skills in Artificial Intelligence (AI), TensorFlow, PyTorch, Machine Learning, Computer Vision, and Deep Learning. Vasco has research experience in neural architecture search models for computer vision applications, risk management, investment strategies, financial operations, banking, and others.
Laurens Asamoah
Laurens is a Visitor Analyst at Calm/Storm Ventures, responsible for strategic partnership planning at HealthtechLisbon, Co-Founder, and CEO at Resyl Health, and Founder Associate at 20x.health. He has a Master's in International Studies from ISCTE - Instituto Universitário de Lisboa, participated in Y Combinator's Startup School 2022, and has a Bachelor in Classical Music - Cello Solo Performance from Escola Superior de Música de Lisboa. His skills include Networking, Operations Management, Partnership Management and Strategy, and Strategic Communication. He has a particular interest in areas such as Healthcare, Start-ups, health tech, and Customer-Relationship-Management (CRM).
Rita Melo
Assertive consensus builder who loves design thinking and project managing. Proven track record in strategic planning, marketing, and market research, mainly in healthcare. Experience spanning from decision support roles and P&L accountable positions, planning, and implementation, working in both large companies and small firms.
Business Model
HealthTech Lisboa supports resident and non-resident startups through a set of services, namely in the areas of:
- Strategic Analysis (Business Model, Business Plan, Team, Pitch Deck, Vision, and Mission, MVP, and Branding).
- Financial Analysis (Due Diligence, Company Evaluation, Budget and Project Analysis, Financing, Financial Structure Optimization and Cost Reduction, Process Improvement, and Audits)
- Financing Search (BAs and VCs, Lost Funds, Banking, and Hybrids)
- Sales and Management (Sales Strategy and Channels, Management Services)
- Core Services (Legal, Administrative, Accounting, Marketing, and Technology)
Active since
2019
Fiscal country
PT
Operating In
Portugal
Industry
Health
Women Shareholders
No
Website
www.healthtechlisboa.comSign up to our newsletter and stay up-to-date on our investment opportunities
HealthTech Portugal
4º Esq
1070-289 Lisboa
Portugal
© 2025 Goparity
GOPARITY (www.goparity.com) is a platform of crowdfunding by loans (crowdlending) managed and owned by Power Parity, SA, a public limited company, with number 514373822, and registered office at Rua Filipe Folque, 2, 1st floor, 1050-110 Lisbon (Portugal), licensed by the regulatory and supervisory body CMVM (Portuguese Securities Market Commission), under Regulation (EU) 2020/1503 (European Crowdfunding Regulation).
The payment services available through the platform are provided by MangoPay SA, a registered electronic money institution based in Luxembourg and supervised by the CSFF (Commission de Surveillance du Secteur Financier), registered with Banco Portugal (the Portuguese regulator) under no. 7830.
Investments in crowdlending carry a risk of a partial or total loss of the funds invested. The return on your investment depends on the project's success developed through the campaign in which you invest. Your investment is not covered by the deposit guarantee schemes established by Directive 2014/49/EU nor by the investor compensation schemes established by Directive 97/9/EU. Please consider all risks before investing and carefully read the Key Investment Information Sheet (KIIS) provided to you before investing.